PROLIA (DENOSUMAB): REVIEW OF THE LATEST PUBLICATIONS OF AMERICAN SOCIETY OF BONE AND MINERAL RESEARCH (ASMBR) IN 2014

PROLIA (DENOSUMAB): REVIEW OF THE LATEST PUBLICATIONS OF AMERICAN SOCIETY OF BONE AND MINERAL RESEARCH (ASMBR) IN 2014

Bibliographic Details
Main Author:	E A Pigarova
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2014-12-01
Series:	Остеопороз и остеопатии
Online Access:	https://endojournals.ru/index.php/osteo/article/view/8895

Similar Items

PROLIA (DENOSUMAB): ANALYSIS OF RECENT PUBLICATIONS FROM THE AMERICAN SOCIETY FOR BONE AND MINERAL RESEARCH (ASMBR) MEETING 2013
by: E A Pigarova
Published: (2013-12-01)

The Effects of Noncompliance to Prolia (Denosumab) on the Changes in Bone Mineral Density: A Retrospective Review
by: Matthew Wong-Pack, et al.
Published: (2016-01-01)

PROLIA (DENOSUMAB) V LEChENII POSTMENOPAUZAL'NOGO OSTEOPOROZA:ANALIZ POSLEDNIKh PUBLIKATsIY
by: E A PIGAROVA
Published: (2013-12-01)

Development of protease-activated Denosumab (Prolia) for postmenopausal osteoporosis therapy
by: Ruei-Cheng You, et al.
Published: (2015)

Experience in using Prolia in patients with postmenopausal osteoporosis in clinical practice
by: I A Skripnikova, et al.
Published: (2017-12-01)

Effect of Denosumab on Bone Mineral Density of Hematopoietic Stem Cell Transplantation Recipients
by: Chaiho Jeong, et al.
Published: (2020-01-01)

Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women
by: Yi Chen, et al.
Published: (2021-04-01)

Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis
by: A. Sánchez, et al.
Published: (2016-01-01)

Pre-treatment of daily teriparatide enhances the increase of bone mineral density in cortical bones by denosumab therapy
by: Kamimura M, et al.
Published: (2018-04-01)

Idiopathic interstitial pneumonias: review of the latest American Thoracic Society/European Respiratory Society classification
by: Daniel Simões Oliveira, et al.
Published: (2018-10-01)

Changes of Bone-Related Minerals during Denosumab Administration in Post-Menopausal Osteoporotic Patients
by: Takako Suzuki, et al.
Published: (2017-08-01)

Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
by: Tetsuya Kaneko, et al.
Published: (2019-10-01)

Denosumab for Male Hemodialysis Patients with Low Bone Mineral Density: A Case-Control Study
by: Hiroya Takami, et al.
Published: (2017-01-01)

Denosumab versus zoledronate for the treatment of low bone mineral density in male HIV-infected patients
by: Polyzois Makras, et al.
Published: (2021-12-01)

Mineral and Bone Consequences of High Dose Denosumab Therapy to Treat an Aneurysmal Bone Cyst, a Child Case Report
by: Giulia Del Sindaco, et al.
Published: (2021-07-01)

Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis
by: Suzuki T, et al.
Published: (2018-03-01)

Effect of risedronate on bone loss at discontinuation of denosumab
by: Michel Laroche, et al.
Published: (2020-12-01)

Efficiency of denosumab in giant cell tumor of the bone
by: N N Semenov
Published: (2013-06-01)

Impact of denosumab on bone mass in cancer patients
by: Brown-Glaberman U, et al.
Published: (2013-07-01)

Preliminary results of an open-label observational study evaluating the efficacy and safety of Prolia used in women with postmenopausal osteoporosis
by: O B Ershova, et al.
Published: (2014-10-01)

Significant improvement of bone mineral density by denosumab treatment in Japanese osteoporotic patients following breast cancer treatment
by: Nakamura Y, et al.
Published: (2018-03-01)

Retrospective Analysis of the Effects of Non-Compliance with Denosumab on Changes in Bone Mineral Density During the COVID-19 Pandemic
by: Huang CF, et al.
Published: (2021-07-01)

Latest homoeopathic research synopsis during July - September (2014)
by: Subhranil Saha, et al.
Published: (2014-01-01)

Latest homoeopathic research synopsis during January - March, 2014
by: Subhranil Saha, et al.
Published: (2014-01-01)

Latest homoeopathic research synopsis during April - June, 2014
by: Subhranil Saha, et al.
Published: (2014-01-01)

The influence of denosumab on one mineral densityand biochemical markers of bone remodeling: results of 6-year phase ii trial
by: P. D. Miller, et al.
Published: (2011-04-01)

Research highlights: Latest homoeopathic research synopsis during October - December 2014
by: Subhranil Saha, et al.
Published: (2015-01-01)

The current standing on the use of denosumab in giant cell tumour of the bone
by: Vivek Ajit Singh, et al.
Published: (2020-12-01)

Denosumab 10-year simulation of bone remodeling in human biopsies
by: Duncan C. Tourolle, et al.
Published: (2020-10-01)

Denosumab in Giant Cell Tumor of Bone: Current Status and Pitfalls
by: Hengyuan Li, et al.
Published: (2020-10-01)

Pharmacoeconomic analysis of denosumab in patients with breast cancer and bone metastases
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report
by: Shinya Otani, et al.
Published: (2019-09-01)

Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion
by: Guenther G. Steger, et al.
Published: (2011-09-01)

Aneurysmal bone cyst: results of an off label treatment with Denosumab
by: Hans Roland Dürr, et al.
Published: (2019-10-01)

Denosumab Therapy for Giant Cell Tumor of Bone Pulmonary Metastasis
by: Ryan Carlisle Egbert, et al.
Published: (2017-01-01)

Giant-cell tumor of bone: treatment options and role of denosumab
by: Singh AS, et al.
Published: (2015-07-01)

Effect of denosumab on bone formation marker P1NP
by: Hitoshi Tanigawa, et al.
Published: (2017-09-01)

Clinical utility of denosumab for treatment of bone loss in men and women
by: Adler R, et al.
Published: (2011-05-01)

A recurrent giant cell tumor of bone treated with denosumab
by: Nicola Stadler, et al.
Published: (2015-02-01)

The Role Of Denosumab
by: Raditya Pria Utama, et al.
Published: (2019-07-01)